« Back to Malignant Tumors of the Skin

Malignant Melanoma

»What is melanoma?
»How common is malignant melanoma in the United States?
»What causes melanoma?
»What groups have a genetic predisposition to familial melanoma?
»List the risk factors for melanoma.
»List the high-risk groups for developing melanoma.
»Do all melanomas develop from atypical nevi?
»What are cancer stem cells?
»Is melanoma a single disease?
»What are the molecular pathways in melanoma?
»Is there a host immune response to melanoma?
»Describe the clinical appearance of melanoma.
»What are the ABCDEs of melanoma?
»What is dermoscopy?
»Where on the body does melanoma most commonly arise?
»Are there different types of melanoma?
»What are Clark’s levels?
»What is Breslow’s depth?
»What other findings should be reported in the histopathologic diagnosis of melanoma?
»What are the common immunohistochemical (IHC) markers utilized in the diagnosis of melanoma?
»Are there other factors with prognostic impact in patients with melanoma?
»How are patients with melanoma evaluated after the initial diagnosis?
»What is the most current system for staging melanoma?
»How is melanoma treated?
»How wide should surgical margins be?
»What is the most important risk factor for local recurrence of primary melanoma?
»Does a biopsy of melanoma increase the risk of spreading tumor cells or causing metastases?
»Describe the recommended follow-up for a patient with melanoma.
»Which tests or examinations are conducted during the routine follow-up of patients who have had melanoma?
»Does local tumor recurrence influence overall survival?
»What is elective lymph node dissection (ELND)? When is it indicated?
»What is sentinel lymph node biopsy? When is it indicated?
»What is linear melanonychia?
»What is Hutchinson’s sign?
»What is Hutchinson’s freckle?
»Are there any new ways to assess prognosis in patients with melanoma?
»What forms of chemotherapy are used in the treatment of metastatic melanoma?
»Is radiation therapy effective for melanoma?
»How effective is immunotherapy in malignant melanoma?
»Does gene therapy offer any better results?
»How about local perfusion?
»What are some newer targeted therapies for melanoma?

 
 
 

Are there different types of melanoma?

A, Superficial spreading malignant melanoma. The lesion shows asymmetry, notched borders, and shades of light brown. B, Superficial spreading malignant melanoma that has developed a nodular melanoma. C, Acral lentiginous melanoma on the sole of the foot demonstrating a macular and focally nodular pigmented lesion with multiple shades of black and gray with a very irregular border. (Panel A courtesy of James E. Fitzpatrick, MD; panel C courtesy of Fitzsimons Army Medical Center teaching files.)
Fig. 45.2 A, Superficial spreading malignant melanoma. The lesion shows asymmetry, notched borders, and shades of light brown. B, Superficial spreading malignant melanoma that has developed a nodular melanoma. C, Acral lentiginous melanoma on the sole of the foot demonstrating a macular and focally nodular pigmented lesion with multiple shades of black and gray with a very irregular border. (Panel A courtesy of James E. Fitzpatrick, MD; panel C courtesy of Fitzsimons Army Medical Center teaching files.)
There are several different types of melanoma, and each may appear somewhat differently:
  • Superficial spreading malignant melanoma (SSMM) is the most common form of melanoma in Caucasians (~70% of cases). It is most commonly diagnosed in the fourth or fifth decade. It usually presents as a slowly enlarging, brown (usually) or black spot that may have both a macular and papular component. The lesion may show color variegation and irregular borders (Fig. 45-2A). About 30% arise in a preexisting nevus, and 75% of these lesions demonstrate regression on clinical exam.
  • Nodular melanoma is the second most common type of melanoma and represents about 15% to 20% of all cases. It is most commonly diagnosed in men between the fifth and sixth decade. Nodular melanoma usually presents as a pigmented (usually brown or black) papule that slowly enlarges and frequently ulcerates. These lesions most commonly present on the head, neck or trunk. Nodular melanomas may ulcerate, presenting as a nonhealing skin ulcer (Fig. 45-2B).
  • Lentigo maligna melanoma, also known as the Hutchinson freckle, represents ~15% of all cases of melanoma. It usually presents as an irregularly shaped, flat, pigmented lesion on actinically damaged skin. It is seen most frequently on the face or other sun-exposed sites. Most patients are in their seventh decade. More advanced lesions can develop papules or nodules, indicating the lesions have developed a vertical or downward growth component.
  • Acral lentiginous melanoma represents 5% to 10% of all cases of melanoma. It is the most common form of melanoma in African-Americans, Asians, and Hispanics (Fig. 45-2C). The latter does not reflect an increase incidence of acral lentiginous melanoma in these races. It usually appears as brown or black macules arising on the glabrous (non–hair-bearing) skin of an extremity (palms, soles, or nail beds). It can also occur on mucosal surfaces. The latter have an extremely poor prognosis.
  • Amelanotic melanoma is usually considered a non–pigment-producing variant of nodular melanoma. Amelanotic melanoma can be confused with other benign skin lesions, such as pyogenic granuloma. Amelanotic melanoma often evades early diagnosis and results in a poorer prognosis.